Conflicting Remdesivir Trial Results Released; Experts Urge More Research 29/04/2020 Grace Ren Preliminary results of a clinical trial released by the US National Institutes of Health (NIH) found that in patients who received remdesivir recovered faster than those who did not receive the treatment. The largest trial to date, which followed 1063 patients, found that patients who received the drug recovered on average 4 days earlier than […] Continue reading -> ‘The World Should Have Listened To WHO’ Says Director General Tedros; Arthritis Drug Shows Promising Results Against COVID-19 In Early Trials 27/04/2020 Grace Ren When the World Health Organization sounded the alarm by declaring a ‘public health emergency of international concern‘ on 30 January, “the world should have listened,” said WHO Director General Dr Tedros Adhanom Ghebreyesus, in his strongest response to date, to repeated allegations by the United States that WHO failed to act quickly enough in the […] Continue reading -> United Nations Approves Second COVID-19 Resolution; Stresses Global Collaboration On R&D, Medicines and Equipment Access 21/04/2020 Editorial team The UN General Assembly approved a resolution Monday night calling for accelerated scientific cooperation and global coordination to hasten the “rapid development, manufacturing and distribution of diagnostics, anti-viral medicines, personal protective equipment and vaccines” needed to fight the COVID-19 pandemic. The resolution, approved in a virtual poll, also called on countries “to immediately take steps […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> WHO Director General Says He “Hopes” US Funding Will Continue Amidst Spate of White House Attacks 14/04/2020 Svĕt Lustig Vijay WHO Director General Dr. Tedros Adhanom Ghebreyesus said on Monday that the relationship between WHO and the United States is “very good” and that, despite the recent maelstrom of criticism by President Donald Trump over WHO’s handling of the COVID-19 crisis, he hoped that funding from the USA will continue. “I hope the funding to […] Continue reading -> The Netherlands Joins COVID-19 IP Pool Initiative; Kentucky Governor Requests 3M Release N95 Patent 08/04/2020 Editorial team Dutch Deputy Prime Minister Hugo de Jonge on Wednesday offered to support the World Health Organization to develop a pool of intellectual property rights for COVID-19 technologies, just days after WHO Director-General Dr Tedros Adhanom Ghebreyesus announced WHO’s public support for the initiative. “In principle, I am sympathetic to this initiative,” Minister de Jonge wrote […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
‘The World Should Have Listened To WHO’ Says Director General Tedros; Arthritis Drug Shows Promising Results Against COVID-19 In Early Trials 27/04/2020 Grace Ren When the World Health Organization sounded the alarm by declaring a ‘public health emergency of international concern‘ on 30 January, “the world should have listened,” said WHO Director General Dr Tedros Adhanom Ghebreyesus, in his strongest response to date, to repeated allegations by the United States that WHO failed to act quickly enough in the […] Continue reading -> United Nations Approves Second COVID-19 Resolution; Stresses Global Collaboration On R&D, Medicines and Equipment Access 21/04/2020 Editorial team The UN General Assembly approved a resolution Monday night calling for accelerated scientific cooperation and global coordination to hasten the “rapid development, manufacturing and distribution of diagnostics, anti-viral medicines, personal protective equipment and vaccines” needed to fight the COVID-19 pandemic. The resolution, approved in a virtual poll, also called on countries “to immediately take steps […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> WHO Director General Says He “Hopes” US Funding Will Continue Amidst Spate of White House Attacks 14/04/2020 Svĕt Lustig Vijay WHO Director General Dr. Tedros Adhanom Ghebreyesus said on Monday that the relationship between WHO and the United States is “very good” and that, despite the recent maelstrom of criticism by President Donald Trump over WHO’s handling of the COVID-19 crisis, he hoped that funding from the USA will continue. “I hope the funding to […] Continue reading -> The Netherlands Joins COVID-19 IP Pool Initiative; Kentucky Governor Requests 3M Release N95 Patent 08/04/2020 Editorial team Dutch Deputy Prime Minister Hugo de Jonge on Wednesday offered to support the World Health Organization to develop a pool of intellectual property rights for COVID-19 technologies, just days after WHO Director-General Dr Tedros Adhanom Ghebreyesus announced WHO’s public support for the initiative. “In principle, I am sympathetic to this initiative,” Minister de Jonge wrote […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
United Nations Approves Second COVID-19 Resolution; Stresses Global Collaboration On R&D, Medicines and Equipment Access 21/04/2020 Editorial team The UN General Assembly approved a resolution Monday night calling for accelerated scientific cooperation and global coordination to hasten the “rapid development, manufacturing and distribution of diagnostics, anti-viral medicines, personal protective equipment and vaccines” needed to fight the COVID-19 pandemic. The resolution, approved in a virtual poll, also called on countries “to immediately take steps […] Continue reading -> GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> WHO Director General Says He “Hopes” US Funding Will Continue Amidst Spate of White House Attacks 14/04/2020 Svĕt Lustig Vijay WHO Director General Dr. Tedros Adhanom Ghebreyesus said on Monday that the relationship between WHO and the United States is “very good” and that, despite the recent maelstrom of criticism by President Donald Trump over WHO’s handling of the COVID-19 crisis, he hoped that funding from the USA will continue. “I hope the funding to […] Continue reading -> The Netherlands Joins COVID-19 IP Pool Initiative; Kentucky Governor Requests 3M Release N95 Patent 08/04/2020 Editorial team Dutch Deputy Prime Minister Hugo de Jonge on Wednesday offered to support the World Health Organization to develop a pool of intellectual property rights for COVID-19 technologies, just days after WHO Director-General Dr Tedros Adhanom Ghebreyesus announced WHO’s public support for the initiative. “In principle, I am sympathetic to this initiative,” Minister de Jonge wrote […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
GlaxoSmithKline & Sanofi Team Up To Develop COVID-19 Vaccine 14/04/2020 Svĕt Lustig Vijay Two of the largest vaccines companies in the world, GlaxoSmithKline (GSK) and Sanofi, are teaming up to hasten vaccine development for COVID-19. “By combining our science and our technologies, we believe we can help accelerate the global effort to develop a vaccine to protect as many people as possible from COVID-19”, said Emma Walmsley, chief […] Continue reading -> WHO Director General Says He “Hopes” US Funding Will Continue Amidst Spate of White House Attacks 14/04/2020 Svĕt Lustig Vijay WHO Director General Dr. Tedros Adhanom Ghebreyesus said on Monday that the relationship between WHO and the United States is “very good” and that, despite the recent maelstrom of criticism by President Donald Trump over WHO’s handling of the COVID-19 crisis, he hoped that funding from the USA will continue. “I hope the funding to […] Continue reading -> The Netherlands Joins COVID-19 IP Pool Initiative; Kentucky Governor Requests 3M Release N95 Patent 08/04/2020 Editorial team Dutch Deputy Prime Minister Hugo de Jonge on Wednesday offered to support the World Health Organization to develop a pool of intellectual property rights for COVID-19 technologies, just days after WHO Director-General Dr Tedros Adhanom Ghebreyesus announced WHO’s public support for the initiative. “In principle, I am sympathetic to this initiative,” Minister de Jonge wrote […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Director General Says He “Hopes” US Funding Will Continue Amidst Spate of White House Attacks 14/04/2020 Svĕt Lustig Vijay WHO Director General Dr. Tedros Adhanom Ghebreyesus said on Monday that the relationship between WHO and the United States is “very good” and that, despite the recent maelstrom of criticism by President Donald Trump over WHO’s handling of the COVID-19 crisis, he hoped that funding from the USA will continue. “I hope the funding to […] Continue reading -> The Netherlands Joins COVID-19 IP Pool Initiative; Kentucky Governor Requests 3M Release N95 Patent 08/04/2020 Editorial team Dutch Deputy Prime Minister Hugo de Jonge on Wednesday offered to support the World Health Organization to develop a pool of intellectual property rights for COVID-19 technologies, just days after WHO Director-General Dr Tedros Adhanom Ghebreyesus announced WHO’s public support for the initiative. “In principle, I am sympathetic to this initiative,” Minister de Jonge wrote […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
The Netherlands Joins COVID-19 IP Pool Initiative; Kentucky Governor Requests 3M Release N95 Patent 08/04/2020 Editorial team Dutch Deputy Prime Minister Hugo de Jonge on Wednesday offered to support the World Health Organization to develop a pool of intellectual property rights for COVID-19 technologies, just days after WHO Director-General Dr Tedros Adhanom Ghebreyesus announced WHO’s public support for the initiative. “In principle, I am sympathetic to this initiative,” Minister de Jonge wrote […] Continue reading -> BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
BCG Vaccine & Ivermectin – Can Old Solutions Be Repurposed For COVID-19? 08/04/2020 Grace Ren & Svĕt Lustig Vijay While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution. Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading -> EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
EMA Releases Guidelines For Compassionate Use of Remdesivir for COVID-19 03/04/2020 Grace Ren The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading -> Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Strong Age-Linked COVID-19 Death Risk Confirmed By Largest-Ever Study Of Chinese Population Infected 31/03/2020 Grace Ren, Svĕt Lustig Vijay & Elaine Ruth Fletcher A new study examining data from nearly 90% of mainland China’s confirmed COVID-19 cases found that the death rate among people older than 80 was 13.4%, as compared to only .32% for people under the age of 60. Almost one in five patients over the age of 80 were likely to require hospitalisation, as compared […] Continue reading -> European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
European Parliament Members Urge Open Licensing For COVID-19 Products Financed Through EU Grants 27/03/2020 Grace Ren Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met. In a separate letter signed by 37 […] Continue reading -> Posts navigation Older postsNewer posts